tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Monte Rosa Therapeutics 11.125M share Secondary priced at $24.00

The deal size was increased to $300M in common stock and pre-funded warrants from $200M. Jefferies, TD Cowen and Piper Sandler acted as joint book running managers for the offering.

Claim 70% Off TipRanks Premium

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1